Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (ACDF) Using Cervios ChronOs™ and Bonion™
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jun 7, 2012
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
Biologically, graft material should be endowed with several basic properties. Several synthetic materials and graft substitutes have been developed to maximize fusion outcomes while avoiding complications of harvesting autograft. Mixture of hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP), have been widely utilized for bony regeneration. On the other hand, demineralized bone matrix (DBM) has been utilized as a graft substitute with mainly its osteoinductive ability. While HA and β-TCP have osteoinductive osteoconductive properties and DBM has osteoconductive osteoinductive properties,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of cervical HIVD, CSR, CSM or OPLL
- • The patient who is expected to receive anterior cervical discectomy and fusion operation.
- • Volunteer for this study with written consent.
- Exclusion Criteria:
- • Patient with cervical spine fracture, infection.
- • Below -3.5 T-score by DEXA bone densitometry
- • Patient with hemorrhagic diseases
- • Patient with malignancy
- • Patient who is not suitable for this study judged by principal investigator
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seongnam Si, Gyeonggi Do, Korea, Republic Of
Patients applied
Trial Officials
Jin Sup Yeom, MD, PhD
Principal Investigator
Seoul National Univerity Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials